LSRCX
Price
$1.08
Change
-$0.00 (-0.00%)
Updated
Jun 22 closing price
Net Assets
406.07M
VSCAX
Price
$33.65
Change
+$0.40 (+1.20%)
Updated
Jun 22 closing price
Net Assets
11.84B
Interact to see
Advertisement

LSRCX vs VSCAX

LSRCX vs VSCAX Comparison Chart in %
View a ticker or compare two or three
VS
LSRCX vs. VSCAX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSRCX is a Buy and VSCAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCAX has more cash in the bank: 11.8B vs. LSRCX (406M). LSRCX pays higher dividends than VSCAX: LSRCX (3.10) vs VSCAX (0.20). LSRCX was incepted earlier than VSCAX: LSRCX (29 years) vs VSCAX (27 years). LSRCX (1.96) is less costly to investors than VSCAX (1.10). LSRCX is a more actively managed with annual turnover of: 69.00 vs. VSCAX (52.00). LSRCX (1000) and VSCAX (1000) have matching initial minimum investment requirements. VSCAX annual gain was more profitable for investors over the last year : 46.78 vs. LSRCX (-35.91). VSCAX return over 5 years is better than : 60.55 vs. LSRCX (-82.52).
LSRCXVSCAXLSRCX / VSCAX
Total Expense Ratio1.961.10178%
Annual Report Gross Expense Ratio1.961.10178%
Fund Existence29 years27 years-
Gain YTD16.12931.37151%
Front LoadN/A6%-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets406M11.8B3%
Annual Yield % from dividends3.100.201,525%
Returns for 1 year-35.9146.78-77%
Returns for 3 years-60.3889.34-68%
Returns for 5 years-82.5260.55-136%
Returns for 10 years-92.11123.05-75%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OVV54.622.21
+4.22%
Ovintiv
TARS63.600.44
+0.70%
Tarsus Pharmaceuticals
CBNK33.360.09
+0.27%
Capital Bancorp
FUSB16.20-0.30
-1.81%
First US Bancshares
BGMS0.68-0.08
-10.29%
Bio Green Med Solution Inc